132 related articles for article (PubMed ID: 12468647)
1. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice.
Kanayama N; Takahashi K; Matsuura T; Sugimura M; Kobayashi T; Moniwa N; Tomita M; Nakayama K
Mol Hum Reprod; 2002 Dec; 8(12):1129-35. PubMed ID: 12468647
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
Knox KS; Baker JC
Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
[TBL] [Abstract][Full Text] [Related]
3. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
Bourcigaux N; Gaston V; Logié A; Bertagna X; Le Bouc Y; Gicquel C
J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
5. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2.
Kihara M; Matsui H; Seki K; Nagai Y; Wake N; Sekiya S
J Reprod Med; 2005 May; 50(5):307-12. PubMed ID: 15971478
[TBL] [Abstract][Full Text] [Related]
6. Impact of diet and stress on the development of preeclampsia-like symptoms in p57kip2 mice.
Falcao S; Solomon C; Monat C; Bérubé J; Gutkowska J; Lavoie JL
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H119-26. PubMed ID: 18978188
[TBL] [Abstract][Full Text] [Related]
7. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
Takahashi K; Kobayashi T; Kanayama N
Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
[TBL] [Abstract][Full Text] [Related]
8. Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and p57Kip2 during mouse development.
Nagahama H; Hatakeyama S; Nakayama K; Nagata M; Tomita K; Nakayama K
Anat Embryol (Berl); 2001 Feb; 203(2):77-87. PubMed ID: 11218061
[TBL] [Abstract][Full Text] [Related]
9. Inducible expression of p57KIP2 inhibits glioma cell motility and invasion.
Sakai K; Peraud A; Mainprize T; Nakayama J; Tsugu A; Hongo K; Kobayashi S; Rutka JT
J Neurooncol; 2004 Jul; 68(3):217-23. PubMed ID: 15332324
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.
Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK
Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation.
Takahashi K; Nakayama K; Nakayama K
J Biochem; 2000 Jan; 127(1):73-83. PubMed ID: 10731669
[TBL] [Abstract][Full Text] [Related]
12. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors.
Hatada I; Inazawa J; Abe T; Nakayama M; Kaneko Y; Jinno Y; Niikawa N; Ohashi H; Fukushima Y; Iida K; Yutani C; Takahashi S; Chiba Y; Ohishi S; Mukai T
Hum Mol Genet; 1996 Jun; 5(6):783-8. PubMed ID: 8776593
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation.
Stewart MC; Kadlcek RM; Robbins PD; MacLeod JN; Ballock RT
J Bone Miner Res; 2004 Jan; 19(1):123-32. PubMed ID: 14753744
[TBL] [Abstract][Full Text] [Related]
14. p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms.
Takahashi K; Amano H; Urano T; Li M; Oki M; Aoki K; Amizuka N; Nakayama KI; Nakayama K; Udagawa N; Higashi N
PLoS One; 2023; 18(2):e0276838. PubMed ID: 36791055
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation.
Nguyen NM; Zhang L; Reddy R; Déry C; Arseneau J; Cheung A; Surti U; Hoffner L; Seoud M; Zaatari G; Bagga R; Srinivasan R; Coullin P; Ao A; Slim R
J Med Genet; 2014 Sep; 51(9):623-34. PubMed ID: 25097207
[TBL] [Abstract][Full Text] [Related]
16. Appropriate expression of P57kip2 drives trophoblast fusion via cell cycle arrest.
Song HL; Liu TH; Wang YH; Li FF; Ruan LL; Adu-Gyamfi EA; Hu SC; Chen XM; Ding YB; Fu LJ
Reproduction; 2021 May; 161(6):633-644. PubMed ID: 33812346
[TBL] [Abstract][Full Text] [Related]
17. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
Genest DR; Dorfman DM; Castrillon DH
J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
[TBL] [Abstract][Full Text] [Related]
18. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
[TBL] [Abstract][Full Text] [Related]
19. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.
Matsuoka S; Thompson JS; Edwards MC; Bartletta JM; Grundy P; Kalikin LM; Harper JW; Elledge SJ; Feinberg AP
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3026-30. PubMed ID: 8610162
[TBL] [Abstract][Full Text] [Related]
20. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.
Hatada I; Mukai T
Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
